Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite for Free

New feature: Introducing the Finviz Matrix

Pluri Inc.

Contributing Author

Recent Articles by Pluri Inc.

Aug-27	Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor PLUR GlobeNewswire
Aug-17	Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment PLUR GlobeNewswire
Jul-28	Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK PLUR GlobeNewswire
Jul-14	Pluri Chairman Alejandro Weinstein's Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30% PLUR GlobeNewswire
Jun-02	Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing PLUR GlobeNewswire
Mar-26	Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement PLUR GlobeNewswire
Feb-18	Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent PLUR GlobeNewswire
Jan-22	Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials PLUR +9.30% GlobeNewswire
Dec-22	Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved PLUR GlobeNewswire
Dec-09	Pluri Appoints Alejandro Weinstein as Chairman of the Board to Lead Strategic Shift and Unlock Value, Backed by Additional Investment PLUR +9.90% GlobeNewswire
Nov-13	Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year PLUR -6.07% GlobeNewswire
Nov-11	Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare PLUR +6.15% GlobeNewswire
Nov-10	Leading Global Players Back and Fund Pluri's Cell-Based Food and Agriculture Collaborations PLUR +18.54% GlobeNewswire
Oct-08	Pluri Subsidiary Coffeesai and Instituto del Cafe de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico PLUR -5.12% GlobeNewswire
May-15	Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion PLUR GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)